You can find more information about mal_mito_3-Cytochrome b using the following links:

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
Antimycin	Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors(2015) Interplay between the hinge region of iron sulphur protein and the Qo site in the bc1 complex - Analysis of Plasmodium-like mutations in the yeast enzyme(2015)
Atovaquone	Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors(2015) Interplay between the hinge region of iron sulphur protein and the Qo site in the bc1 complex - Analysis of Plasmodium-like mutations in the yeast enzyme(2015) Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites(2017) Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors(2018)
Azoxystrobin	Interplay between the hinge region of iron sulphur protein and the Qo site in the bc1 complex - Analysis of Plasmodium-like mutations in the yeast enzyme(2015)
CK-2-68	Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors(2018)
Metabolic network analysis, suggested target	Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis(2010)
Ml-238	Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors(2015)
N-(3-isobutyramidophenyl)-3-(2-oxobenzo[d]thiazol-3(2H)-yl)propanamide	High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of Pf DHODH and Pf Cytbc1 complex to combat drug resistant malaria(2020)
N-(4-Chloro-2,5-dimethoxyphenyl)-2-[(9-oxo-9,10-dihydro-2-acridinyl)oxy]acetamide	Open-source discovery of chemical leads for next-generation chemoprotective antimalarials(2018)
N-cyclopropyl-5-[(4-methylphenyl)methylsulfanylmethyl]furan-2-carboxamide	Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum(2016)
Quinolone	Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria(2012)
RYL-552	Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors(2018)
TCMDC-136129	Identification of Collateral Sensitivity to Dihydroorotate Dehydrogenase Inhibitors in Plasmodium falciparum(2018)